Discover
All our news News Conferences & events | 01.24.23
XenTech will attend the DDR inhibitors Summit 2023 (Boston, Jan. 24-26)
Discover how our World-Class Breast PDX panel has been key to PARP and DDRi Research !
Olivier Deas, our Head of R&D, will be delighted to meet-up with you there and explain how our specifically well characterized Breast Cancer panel has been detrimental to all PARP/DDRi research as of now. If you’re involved in PARP/DDR inhibitors’ development, you have to talk with us; we’ll share our experience and expertise with real pleasure !
XenTech proudly delivers reliable and actionnable results you can build upon !
Visit DDRi Summit 23 website
Xentech is willing to accelerate the preclinical development/validation of new anti-cancer therapeutics with a growing panel of highly predictive human tumor-based models and robust screening/profiling studies.
Looking forward to welcoming you at booth #538 or in front of the posters !
We'll be exhibiting at EORTC-NCI-AACR in Barcelona, stop by booth #17 !
Olivier, Vincent and Marie cordially invite you to stop by our Booth#3645 to discuss your innovative research projects.
